BBG Advanced Therapies Launches Mobile Leukapheresis Center, in Collaboration with Kite to Bring CAR T-cell Therapies Closer to Patients

BBG Advanced Therapies, a subsidiary of San Antonio-based nonprofit BioBridge Global, today announced a collaboration ...

Emmecell Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EO2002 for the Treatment of Corneal Endothelial Disease

Emmecell receives FDA RMAT designation for EO2002, advancing development of its regenerative cell therapy for corneal ...
Morningstar

Advanced Cell-based Therapy Booming the Success for Healthcare Sector

Issued on behalf of Avaí Bio, Inc. VANCOUVER, BC, March 24, 2026 /PRNewswire/ -- USANewsGroup.com — The FDA has approved more than 40 cell and gene therapy products. The regenerative medicine market ...
Medical Xpress

An aggressive childhood cancer case opens new avenues for advanced cell therapies

Although relatively rare, many childhood cancers remain life-threatening and lack effective personalized treatments. Rhabdoid tumors are among these fatal cancers and can develop in various tissues ...

Centre Brings Advanced Cell And Gene Therapies Under Stricter Licensing Framework

India has brought cell/stem-cell therapies, gene therapies and xenografts under CLAA oversight, requiring central and state approval to boost safety, uniform standards and regulation of advanced ...
The Scientist

Cell Therapy Types, Uses, and Future Impacts

Cell therapy is an advanced biomedical approach that utilizes living cells as therapeutic agents to treat disease or repair tissue. 4 Scientists isolate cells from a patient or a healthy donor and ...

Scaling Advanced Therapies and U.S. Biomanufacturing

ElevateBio industrializes cell and gene therapy manufacturing, using automation and AI to bring life-changing genetic ...

Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, an…

Persistence Market Research, a leading management consulting firm, has released this update on the cell culture media market.

Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance

Recently, Porton Advanced proudly announced that its Umbilical Cord-Derived Mesenchymal Stem Cell (UC-MSCs) Cell Bank for exosome ...

CCRM, OmniaBio and Avectas Partner to Improve Cell Therapy Manufacturing

CCRM and its CDMO subsidiary OmniaBio Inc., today announced an agreement with Avectas Limited ("Avectas") to evaluate its automated, integrated and scalable cell therapy manufacturing platform. The ...